Entry |
|
Name |
Darodipine (USAN/INN) |
Formula |
C19H21N3O5
|
Exact mass |
371.1481
|
Mol weight |
371.39
|
Structure |
|
Simcomp |
|
Class |
Cardiovascular agent
DG01575 Calcium channel blocker
DG01496 Calcium channel L type blocker
DG03231 Antihypertensive
DG01928 Dihydropyridine calcium channel blocker
|
Efficacy |
Antihypertensive, Bronchodilator, Vasodilator, Calcium channel blocker |
Comment |
Dihydropyridine derivative
|
Target |
|
Pathway |
hsa04261 | Adrenergic signaling in cardiomyocytes |
hsa04270 | Vascular smooth muscle contraction |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Cardiovascular agent
DG01575 Calcium channel blocker
DG01496 Calcium channel L type blocker
D03655 Darodipine
DG03231 Antihypertensive
DG01928 Dihydropyridine calcium channel blocker
D03655 Darodipine
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Calcium channels
CACNA1-L
D03655 Darodipine (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 27
1 C1y C 9.7763 -6.4487
2 C2y C 10.9861 -5.7370
3 C2y C 8.5665 -5.7370
4 C8y C 9.7763 -8.8682
5 C2y C 10.9861 -4.3849
6 C7a C 12.1958 -6.4487
7 C2y C 8.5665 -4.3849
8 C7a C 7.4279 -6.3775
9 C8x C 10.9861 -9.5798
10 C8y C 8.5665 -9.5798
11 N1x N 9.7763 -3.6733
12 C1a C 12.1958 -3.6733
13 O7a O 13.3345 -5.7370
14 O6a O 12.1958 -7.8008
15 C1a C 7.4279 -3.6733
16 O7a O 6.2182 -5.7370
17 O6a O 7.4279 -7.8008
18 C8x C 10.9861 -10.8608
19 C8y C 8.5665 -10.8608
20 C1b C 14.5442 -6.4487
21 C1b C 5.0084 -6.3775
22 C8x C 9.7763 -11.5724
23 C1a C 15.7826 -5.7471
24 N5x N 7.3483 -9.1840
25 O2x O 6.5953 -10.2203
26 N5x N 7.3483 -11.2566
27 C1a C 3.8421 -5.6454
BOND 29
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 2
7 3 8 1
8 4 9 2
9 4 10 1
10 5 11 1
11 5 12 1
12 6 13 1
13 6 14 2
14 7 15 1
15 8 16 1
16 8 17 2
17 9 18 1
18 10 19 1
19 13 20 1
20 16 21 1
21 18 22 2
22 7 11 1
23 19 22 1
24 20 23 1
25 10 24 2
26 24 25 1
27 25 26 1
28 19 26 2
29 21 27 1
|